Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice

BACKGROUND: Melanoma is one of the most common types of skin malignancies. Since current therapies are suboptimal, considerable interest has focused on novel natural-based treatments. Toll-like receptors (TLRs) play an important role in evoking innate immunity against cancer cells. Zymosan, a known...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghavi, Mehdi, Mortaz, Esmaeil, Khosravi, Alireza, Vahedi, Ghasem, Folkerts, Gert, Varahram, Mohammad, Kazempour-Dizaji, Mehdi, Garssen, Johan, Adcock, Ian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863857/
https://www.ncbi.nlm.nih.gov/pubmed/29588627
http://dx.doi.org/10.1186/s12950-018-0182-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863857/
https://www.ncbi.nlm.nih.gov/pubmed/29588627
http://dx.doi.org/10.1186/s12950-018-0182-y

Ejemplares similares